RAN, Fluigent Ink Distribution Agreement for Europe | GenomeWeb

NEW YORK (GenomeWeb) – Fluigent will distribute RAN Biotechnologies' products in Europe, RAN announced today.

RAN is a provider of chemicals for microfluidic and biotech applications, including fluorosurfactants and microfluidic surface coatings for stabilizing water-in-oil emulsions for droplet microfluidics and encapsulating biological molecules, such as DNA, RNA, cells, and proteins. According to the Beverly, Mass.-based firm, droplet microfluidics is an alternative to lab-on-a-chip technology that is compatible with many chemicals and biological molecules.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: proteomic consequences of genomic changes in ovarian cancer, Human SRMAtlas, and more.

At Nature, John Wilbanks and Eric Topol call for openness in health data.

Law.com predicts that genomic and genetic testing will become common in toxic tort cases.

A Pew Research Center report finds that most Americans are wary of using technologies like gene editing to enhance human abilities.